The curcumin analog ca27 down-regulates androgen receptor through an oxidative stress mediated mechanism in human prostate cancer cells
BACKGROUND The androgen receptor (AR) plays a critical role in prostate cancer development and progression. Therefore, the inhibition of AR function is an established therapeutic intervention. Since the expression of the AR is retained and often increased in progressive disease, AR protein down‐regu...
Saved in:
Published in: | The Prostate Vol. 72; no. 6; pp. 612 - 625 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01-05-2012
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | BACKGROUND
The androgen receptor (AR) plays a critical role in prostate cancer development and progression. Therefore, the inhibition of AR function is an established therapeutic intervention. Since the expression of the AR is retained and often increased in progressive disease, AR protein down‐regulation is a promising therapeutic approach against prostate cancer. We show here that the curcumin analog 27 (ca27) down‐regulates AR expression in several prostate cancer cell lines.
METHODS
ca27 at low micromolar concentrations was tested for its effect on AR expression, AR activation, and induction of oxidative stress in human LNCaP, C4‐2, and LAPC‐4 prostate cancer cells.
RESULTS
ca27 induced the down‐regulation of AR protein expression in LNCaP, C4‐2, and LAPC‐4 cells within 12 hr. Further, ca27 led to the rapid induction of reactive oxygen species (ROS). To further support this finding, ca27 treatment led to the activation of the cellular redox sensor NF‐E2‐related factor 2 (Nrf2) and the induction of the Nrf2‐regulated genes NAD(P)H quinone oxidoreductase 1 and aldoketoreductase 1C1. We show that ROS production preceded AR protein loss and that ca27‐mediated down‐regulation of the AR was attenuated by the antioxidant, N‐acetyl cysteine.
CONCLUSIONS
ca27 induces ROS and mediates AR protein down‐regulation through an oxidative stress mechanism of action. Our results suggest that ca27 represents a novel agent for the elucidation of mechanisms of AR down‐regulation, which could lead to effective new anti‐androgenic strategies for the treatment of advanced prostate cancer. Prostate 72:612–625, 2012. © 2011 Wiley Periodicals, Inc. |
---|---|
Bibliography: | ArticleID:PROS21464 National Institutes of Health (NIH) Grant - No. RR0164880 Department of Defense (DOD) Prostate Cancer Program Grant - No. PC060864/W81XWH-07-1-0081 DOD Breast Cancer Program Grant - No. BC043125 University of New Mexico Cancer Center Support Grant - No. NIH/NCI P30CA118110 istex:7636F117FEAFA897BC6A2AC394584D1AE4294D7D Pfizer Safety Scholars Fellowship NIH Grant - No. 1 R03 CA133941 ark:/67375/WNG-VN70D3G0-5 |
ISSN: | 0270-4137 1097-0045 |
DOI: | 10.1002/pros.21464 |